COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,711 Articles (22,913 medRxiv, 8,798 bioRxiv)

Most recent first Previous |  Page 2892: Articles 28911-28920  | Next

Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study
Yin, R., Yang, Z., Wei, Y., Li, Y., Chen, H., Ma, D., Dan, M., Zhang, Y., Liu, X., Leng, H., Xiang, D.
10.1101/2020.04.29.20085415 — Posted: 2020-05-05
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo
Takita, M., Matsumura, T., Yamamoto, K., Yamashita, E., Hosoda, K., Hamaki, T., Kusumi, E.
10.1101/2020.04.29.20085449 — Posted: 2020-05-05 Discussion: Onsite
Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam
Wong, J., Koh, W. C., Momin, R. N., Alikhan, M. F., Fadillah, N., Naing, L.
10.1101/2020.04.30.20086082 — Posted: 2020-05-05
Characteristics of lymphocyte subsets and their predicting values for the severity of COVID-19 patients
Wang, J., Dong, X., Zhang, B., Yang, X., Li, Z., Wang, X., Zuo, S.
10.1101/2020.05.01.20086421 — Posted: 2020-05-05 Discussion: Onsite | Offsite
AN INTERACTIVE COVID-19 MOBILITY IMPACT AND SOCIAL DISTANCING ANALYSIS PLATFORM
Zhang, L., Ghader, S., Pack, M. L., Xiong, C., Darzi, A., Yang, M., Sun, Q., Kabiri, A., Hu, S.
10.1101/2020.04.29.20085472 — Posted: 2020-05-05
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Vuagnat, P., Frelaut, M., Ramtohul, T., Basse, C., Diakite, S., Noret, A., Bellesoeur, A., Servois, V., Hequet, D., Laas, E., Kirova, Y., Cabel, L., Pierga, J.-Y., Institut Curie Breast Cancer and COVID Group, , Bozec, L., Paoletti, X., Cottu, P., Bidard, F.-C.
10.1101/2020.04.30.20085928 — Posted: 2020-05-05
Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia
Mohamad, E. M., Azlan, A. A., Hamzah, M. R., Tham, J. S., Ayub, S. H.
10.1101/2020.04.29.20085563 — Posted: 2020-05-05
A systematic review to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Grover, A., Oberoi, M.
10.1101/2020.04.29.20085787 — Posted: 2020-05-05
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: an Exploratory Randomized, Controlled Trial
Lou, Y., Liu, L., Qiu, Y.
10.1101/2020.04.29.20085761 — Posted: 2020-05-05 Discussion: Onsite
Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19
Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Kazmierski, J., Timmermann, B., Twardziok, S., Schneider, S., Machleidt, F., Müller-Redetzky, H., Krannich, A., Schmidt, S., Balzer, F., Liebig, J., Loske, J., Eils, J., Ishaque, N., von Kalle, C., Hocke, A., Witzenrath, M., Goffinet, C., Drosten, C., Laudi, S., Lehmann, I., Conrad, C., Sander, L.-E., Eils, R.
10.1101/2020.04.29.20084327 — Posted: 2020-05-05 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).